Request Sample Inquiry
Prostate Specific Antigen (psa) Testing Market

Prostate Specific Antigen (PSA) Testing Market

Prostate Specific Antigen (PSA) Testing Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

159

Base Year:

2022

Date

Feb - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1321

Segments Covered
  • By Test Type By Test Type Preliminary Tests, Confirmatory Tests
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 3.33 Billion
Revenue 2030Revenue 2030: USD 7.74 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 11.10%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst

Prostate Specific Antigen (PSA) Testing Market Segment Analysis

  • Prostate Specific Antigen (PSA) Testing Test Type Outlook (Revenue, USD Million, 2018 - 2030)
    • Preliminary Tests
    • Confirmatory Tests
  • Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
    • North America
      • North America Prostate Specific Antigen (PSA) Testing Market, by Test Type
        • Preliminary Tests
        • Confirmatory Tests
      • U.S.
        • U.S. Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
      • Canada
        • Canada Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
      • Mexico
        • Mexico Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
    • Europe
      • Europe Prostate Specific Antigen (PSA) Testing Market, by Test Type
        • Preliminary Tests
        • Confirmatory Tests
      • U. K.
        • U.K. Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
      • France
        • France Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
      • Germany
        • Germany Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
      • Italy
        • Italy Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
      • Spain
        • Spain Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
      • Rest of Europe
        • Rest of Europe Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
    • Asia Pacific
      • Asia Pacific Prostate Specific Antigen (PSA) Testing Market, by Test Type
        • Preliminary Tests
        • Confirmatory Tests
      • China
        • China Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
      • Japan
        • Japan Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
      • Germany
        • Germany Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
      • India
        • India Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
      • South Korea
        • South Korea Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
      • South East Asia
        • South East Asia Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
      • Rest of Asia Pacific
        • Rest of Asia Pacific Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
    • Latin America
      • Latin America Prostate Specific Antigen (PSA) Testing Market, by Test Type
        • Preliminary Tests
        • Confirmatory Tests
      • Brazil
        • Brazil Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
      • Argentina
        • Argentina Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
      • Rest of Latin America
        • Rest of Latin America Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
    • Middle East & Africa
      • Middle East & Africa Prostate Specific Antigen (PSA) Testing Market, by Test Type
        • Preliminary Tests
        • Confirmatory Tests
      • GCC Countries
        • GCC Countries Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
      • South Africa
        • South Africa Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
      • Rest of Middle East & Africa
        • Rest of Middle East & Africa Prostate Specific Antigen (PSA) Testing Market, by Test Type
          • Preliminary Tests
          • Confirmatory Tests
FAQ
Frequently Asked Question
  • The global Prostate Specific Antigen (PSA) Testing valued at USD 3.33 Billion in 2022 and is expected to reach USD 7.74 Billion in 2030 growing at a CAGR of 11.10%.

  • The prominent players in the market are MDx Health (US), Myriad Genetics Inc (US)., Abbott Laboratories (US), F. Hoffman-La Roche AG (Switzerland), Siemens Healthineers AG (Germany), OPKO Health Inc. (US), and Genomic Health (US)..

  • The market is project to grow at a CAGR of 11.10% between 2023 and 2030.

  • The driving factors of the Prostate Specific Antigen (PSA) Testing include

    • Increased Level of Awareness

  • North America was the leading regional segment of the Prostate Specific Antigen (PSA) Testing in 2022.